SPECULATOR: What if we're wrong? (All-Value edition)

Even with the end of April in sight, it's still a little early to perform meaningful performance validation analysis. 50-60 AB for hitters and a handful of starts for pitchers can't tell us much of anything. That doesn't mean we aren't looking, though. And if we must do some level of early performance validation, what better place to speculate than on our All-Value and All-Avoid teams, as identified in March over in the Market Pulse column. In the case of the All-Value team, this is a collection of players that end up owned by a decent percentage of BaseballHQ.com readers. In the case of the All-Avoid team, identifying cases where the marketplace is properly evaluating players may help identify acquisition targets over the coming...

More From Speculator